Nilai Buku saben Saham: Vanda Pharmaceuticals (VNDA)

This daily price chart for Vanda Pharmaceuticals (VNDA) on the GURU.Markets platform reflects the business dynamics of a company whose revenues are based on the sale of therapies for CNS and sleep disorders. The current indicator stands at 3.61, while the company's success depends on the outcome of patent litigation and the expansion of insurance reimbursements. The company optimizes processes by outsourcing production and logistics to external partners, and its independence from macroeconomic trends makes the asset a reliable defensive play.

This indicator reflects the net asset value per share, allowing a conservative investor to determine the intrinsic value of the business while filtering out market noise. By analyzing the reported book value per share, one can correlate the capital stability of Vanda Pharmaceuticals (VNDA) with its authority in the treatment of severe psychiatric disorders, using this metric as a foundation for assessing long-term investment attractiveness.